BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37144587)

  • 61. Introduction of liquid-based cytology and human papillomavirus testing in cervical cancer screening in Luxembourg.
    Latsuzbaia A; Hebette G; Fischer M; Arbyn M; Weyers S; Vielh P; Schmitt F; Mossong J
    Diagn Cytopathol; 2017 May; 45(5):384-390. PubMed ID: 28247516
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Evaluation of the effectiveness of BMRT-HPV for cervical cancer screening].
    Duan LF; Du H; Wang C; Huang X; Qu XF; Duan XZ; Liu Y; Shi B; Zhang W; Wei LH; Belinson L; Wu RF
    Zhonghua Fu Chan Ke Za Zhi; 2020 Oct; 55(10):708-715. PubMed ID: 33120484
    [No Abstract]   [Full Text] [Related]  

  • 63. Triage of HPV positive women in cervical cancer screening.
    Wentzensen N; Schiffman M; Palmer T; Arbyn M
    J Clin Virol; 2016 Mar; 76 Suppl 1(Suppl 1):S49-S55. PubMed ID: 26643050
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Evaluation of several screening approaches for detection of cervical lesions in rural Shandong, China.
    Zong LJ; Zhang YZ; Yang XS; Jiang J; Cui BX; Qiao YB; Li L; Jiang K; Zhang WJ; Kong BH; Shen K
    Asian Pac J Cancer Prev; 2015; 16(5):1907-12. PubMed ID: 25773843
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Racial and Ethnic Differences in Acceptability of Urine and Cervico-Vaginal Sample Self-Collection for HPV-Based Cervical Cancer Screening.
    Rohner E; McGuire FH; Liu Y; Li Q; Miele K; Desai SA; Schmitt JW; Knittel A; Nelson JAE; Edelman C; Sivaraman V; Baker A; Romocki LS; Rahangdale L; Smith JS
    J Womens Health (Larchmt); 2020 Jul; 29(7):971-979. PubMed ID: 32212991
    [No Abstract]   [Full Text] [Related]  

  • 66. Performance of visual inspection of the cervix with acetic acid (VIA) for triage of HPV screen-positive women: results from the ESTAMPA study.
    Baena A; Mesher D; Salgado Y; Martínez S; Villalba GR; Amarilla ML; Salgado B; Flores B; Bellido-Fuentes Y; Álvarez-Larraondo M; Valls J; Lora O; Virreira-Prout G; Figueroa J; Turcios E; Soilán AM; Ortega M; Celis M; González M; Venegas G; Terán C; Ferrera A; Mendoza L; Kasamatsu E; Murillo R; Wiesner C; Broutet N; Luciani S; Herrero R; Almonte M;
    Int J Cancer; 2023 Apr; 152(8):1581-1592. PubMed ID: 36451311
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Evaluation of portable colposcopy and human papillomavirus testing for screening of cervical cancer in rural China.
    Newman H; Hu J; Li X; He J; Bradford L; Shan S; Wu X; Zhu B; Yang W; Fu B; Zhu B; Gao G
    Int J Gynecol Cancer; 2019 Jan; 29(1):23-27. PubMed ID: 30640679
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening.
    Naucler P; Ryd W; Törnberg S; Strand A; Wadell G; Elfgren K; Rådberg T; Strander B; Forslund O; Hansson BG; Hagmar B; Johansson B; Rylander E; Dillner J
    J Natl Cancer Inst; 2009 Jan; 101(2):88-99. PubMed ID: 19141778
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Human Papillomavirus Assays and Cytology in Primary Cervical Screening of Women Aged 30 Years and Above.
    Rebolj M; Bonde J; Preisler S; Ejegod D; Rygaard C; Lynge E
    PLoS One; 2016; 11(1):e0147326. PubMed ID: 26789267
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Performance of visual inspection with acetic acid and human papillomavirus testing for detection of high-grade cervical lesions in HIV positive and HIV negative Tanzanian women.
    Dartell MA; Rasch V; Iftner T; Kahesa C; Mwaiselage JD; Junge J; Gernow A; Ejlersen SF; Munk C; Kjaer SK
    Int J Cancer; 2014 Aug; 135(4):896-904. PubMed ID: 24391021
    [TBL] [Abstract][Full Text] [Related]  

  • 71. HPV detection in a self-collected vaginal swab combined with VIA for cervical cancer screening with correlation to histologically confirmed CIN.
    Kamal EM; El Sayed GA; El Behery MM; El Shennawy GA
    Arch Gynecol Obstet; 2014 Dec; 290(6):1207-13. PubMed ID: 25009070
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Management of HPV-positive women in cervical screening using results from two consecutive screening rounds.
    Polman NJ; Veldhuijzen NJ; Heideman DAM; Snijders PJF; Meijer CJLM; Berkhof J
    Int J Cancer; 2019 May; 144(9):2339-2346. PubMed ID: 30565673
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Minimally abnormal Pap testing and cervical histology in HIV-infected women.
    Curry CL; Sage YH; Vragovic O; Stier EA
    J Womens Health (Larchmt); 2012 Jan; 21(1):87-91. PubMed ID: 22011239
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The Mexican Cervical Cancer Screening Trial: self-sampling for human papillomavirus with unaided visual inspection as a secondary screen.
    Belinson JL; Pretorius RG; Enerson C; Garcia F; Cruz EP; Belinson SE; Yeverino García E; Brainard J
    Int J Gynecol Cancer; 2009 Jan; 19(1):27-32. PubMed ID: 19258937
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Study on the value assessment of various screening programs regarding cervical cancer screening strategy in the rural areas of China].
    Li LY; Qiao ZQ; Zhang MF; Yang JP; Bao YP; An YT; Lei J; Xiong NH; Yu XH; Zhang X; Pan QJ; Qiao YL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Oct; 28(10):964-7. PubMed ID: 18399140
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Persistence and clearance of high-risk human papillomavirus and cervical dysplasia at 1 year in women living with human immunodeficiency virus: a prospective cohort study.
    Luckett R; Painter H; Hacker MR; Simon B; Seiphetlheng A; Erlinger A; Eakin C; Moyo S; Kyokunda LT; Esselen K; Feldman S; Morroni C; Ramogola-Masire D
    BJOG; 2021 Nov; 128(12):1986-1996. PubMed ID: 34008294
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Liquid-based cytology and human papillomavirus testing: a pooled analysis using the data from 13 population-based cervical cancer screening studies from China.
    Pan QJ; Hu SY; Guo HQ; Zhang WH; Zhang X; Chen W; Cao J; Jiang Y; Zhao FH; Qiao YL
    Gynecol Oncol; 2014 May; 133(2):172-9. PubMed ID: 24631450
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Primary cervical cancer screening and triage using an mRNA human papillomavirus assay and visual inspection.
    Nieves L; Enerson CL; Belinson S; Brainard J; Chiesa-Vottero A; Nagore N; Booth C; Pérez AG; Chávez-Avilés MN; Belinson J
    Int J Gynecol Cancer; 2013 Mar; 23(3):513-8. PubMed ID: 23334437
    [TBL] [Abstract][Full Text] [Related]  

  • 79. HPV screening for cervical cancer in rural India.
    Sankaranarayanan R; Nene BM; Shastri SS; Jayant K; Muwonge R; Budukh AM; Hingmire S; Malvi SG; Thorat R; Kothari A; Chinoy R; Kelkar R; Kane S; Desai S; Keskar VR; Rajeshwarkar R; Panse N; Dinshaw KA
    N Engl J Med; 2009 Apr; 360(14):1385-94. PubMed ID: 19339719
    [TBL] [Abstract][Full Text] [Related]  

  • 80. CyclinA1 Promoter Methylation in Self-Sampling Test.
    Oranratanaphan S; Kengsakul M; Triratanachat S; Kitkumthorn N; Mutirangura A; Termrungruanglert W
    Asian Pac J Cancer Prev; 2020 Oct; 21(10):2913-2917. PubMed ID: 33112548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.